Maryland neurodegenerative disease therapy firm raises $10.5M in equity funding
April 23, 2018 / Tina Reed
Neurodegenerative disease therapies, population health and a company making drugs for dry eye were among health companies in the U.S. that are in the midst of or closed fundraising rounds in the last week. Curious about who is raising money? Here are some of the latest deals in healthcare: Germantown, Maryland-based Neuraly Inc., a company that is working on therapeutics for neurodegenerative diseases including Parkinson's and Alzheimer's, raised $10.5 million in equity funding. The CEO of the company is Seulki Lee, an assistant professor of radiology, ophthalmology and materials science and engineering and a member of the Johns Hopkins Kimmel Cancer Center. The company did not specify what the funding is for.